{"id":36344,"date":"2019-07-17T08:00:11","date_gmt":"2019-07-17T08:00:11","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=36344"},"modified":"2019-07-26T04:15:28","modified_gmt":"2019-07-26T04:15:28","slug":"36344","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/36344","title":{"rendered":"HTB 17 July 2019 online: IAS 2019, HIV pipeline, gene-cure mice&#8230;"},"content":{"rendered":"<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-36345\" src=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2019\/07\/HTB-17-July-2019-no-8-cover-209x300.png\" alt=\"\" width=\"183\" height=\"261\" srcset=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2019\/07\/HTB-17-July-2019-no-8-cover-768x1100.png 768w, https:\/\/i-base.info\/htb\/wp-content\/uploads\/2019\/07\/HTB-17-July-2019-no-8-cover-715x1024.png 715w, https:\/\/i-base.info\/htb\/wp-content\/uploads\/2019\/07\/HTB-17-July-2019-no-8-cover.png 1140w\" sizes=\"auto, (max-width: 183px) 100vw, 183px\" \/><\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/date\/2019\/07\/17\" rel=\"noopener\">Contents online<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/36364\">PDF of this issue<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/forms\/esub.php\">Subscribe by email<\/a><\/li>\n<\/ul>\n<p><strong>This slim issue of HTB includes a hint of what to expect from the upcoming 10th IAS Conference on HIV Science (IAS 2019) in Mexico City.<\/strong><\/p>\n<p>The EMA has also approved the fixed dose dual combination of dolutegravir\/lamivudine (and expect IAS 2019 to include more data on this combination).<\/p>\n<p>This and other compounds in the HIV pipeline are included in the i-Base 2019 Pipeline report, and we include the full report as a supplement.<\/p>\n<p>IAS-USA have updated their guidelines on mutations associated with HIV drug resistance.<\/p>\n<p>Richard Jefferys provides expert analysis both on the recent report of gene editing being used to cure mice and the inability of mainstream press to report this accurately.<\/p>\n<p>Appropriately for the summer holiday season, USAIDS calls again for lifting all HIV-related travel restrictions. If you are travelling, the list of countries to avoid is included.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Contents online PDF of this issue Subscribe by email This slim issue of HTB includes a hint of what to expect from the upcoming 10th IAS Conference on HIV Science (IAS 2019) in Mexico City. The EMA has also approved &hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-36344","post","type-post","status-publish","format-standard","hentry","category-editorial"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/36344","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=36344"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/36344\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=36344"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=36344"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=36344"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}